Particles for Industrial and Environmental Applications

Publication ID: 24-11857694_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Particles for Industrial and Environmental Applications,” Published Technical Disclosure No. 24-11857694_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857694_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,694.

Summary of the Inventive Concept

The present inventive concept expands the application of embolic particles to new industries, including environmental remediation, agricultural pest control, industrial pipeline maintenance, water conservation, and food safety assurance.

Background and Problem Solved

The original patent disclosed embolic particles for medical purposes, such as occluding vascular defects. However, these particles have untapped potential for addressing various industrial and environmental challenges. The present inventive concept addresses the limitation of the original patent by adapting the embolic particles for use in these new fields.

Detailed Description of the Inventive Concept

The inventive concept involves using embolic particles, similar to those described in the original patent, but with modified properties and delivery mechanisms tailored to specific industrial and environmental applications. For instance, the particles can be designed to occlude and contain oil spills in marine ecosystems, block nutrient pathways to prevent pest growth in agricultural settings, or repair pipeline defects in industrial infrastructure. The particles can be delivered through microcatheters, micro-irrigation systems, or other specialized devices.

Novelty and Inventive Step

The new claims introduce novel applications and use cases for the embolic particles, which were not anticipated by the original patent. The inventive step lies in recognizing the potential of these particles to address diverse industrial and environmental challenges, and adapting their design and delivery to meet the specific needs of these fields.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using different materials or shapes for the embolic particles, or developing new delivery mechanisms, such as drones or autonomous underwater vehicles, to expand their reach and versatility.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential across various industries, including environmental remediation, agriculture, industrial maintenance, water conservation, and food safety. The target market includes companies, governments, and organizations seeking innovative solutions to address pressing environmental and industrial challenges.

CPC Classifications

SectionClassGroup
A A61 A61L24/06
A A61 A61L24/001
C C08 C08F222/385
A A61 A61L2430/36

Field of Art

Biomedical engineering and materials science, specifically focused on injectable particle systems for medical and industrial applications, with expertise in polymer chemistry, microcatheter delivery systems, and particle design

Person of Ordinary Skill (PHOSITA) Profile

A skilled practitioner with advanced degrees in chemical engineering or biomedical engineering, experienced in polymer synthesis, medical device design, and understanding of particle transformation mechanisms

Obviousness Rationale

A person of ordinary skill would recognize that the fundamental particle design from the source patent enables broad application across multiple domains by simply adapting delivery mechanisms and targeting specific containment or occlusion challenges. The core technological innovation of size-transformable particles with microcatheter compatibility provides a versatile platform that can be readily extended to industrial and environmental contexts. The PTD demonstrates predictable variations that leverage the existing particle technology's inherent adaptability.

Obvious Combinations & Variations

Source Patent Element
Embolic particles designed to fit through microcatheters with diameter constraints (0.0155-0.0170 inch)
PTD Variation
Applying identical particle delivery mechanism to environmental remediation via specialized micro-injection systems
Obviousness Reasoning
Microcatheter compatibility is a known technique for precise particle delivery, and adapting this to different injection contexts represents a predictable design extension
Source Patent Element
Reaction product of polyether macromer and ethylenic unsaturation monomer
PTD Variation
Modifying particle chemical composition to enhance environmental interaction and containment properties
Obviousness Reasoning
Material science practitioners would recognize routine chemical modifications as an obvious approach to tailoring particle performance for specific applications
Source Patent Element
Particles capable of size transformation after initial injection
PTD Variation
Leveraging size-change mechanism for blocking nutrient pathways, pipeline defects, or bacterial contamination zones
Obviousness Reasoning
The inherent expandable nature of the particles provides a predictable solution for occlusion challenges across multiple domains
Source Patent Element
Medical occlusion particle design principles
PTD Variation
Translating medical particle technology to industrial and environmental containment scenarios
Obviousness Reasoning
Cross-domain technology transfer represents a standard innovation pathway for solving analogous containment and blocking challenges
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857694, a person having ordinary skill in the art would find the proposed variations in industrial and environmental particle applications to be obvious extensions of the existing embolic particle technology. The fundamental particle design principles, including microcatheter compatibility and size-transformative capabilities, provide a predictable technological framework that can be readily adapted across multiple technical domains without requiring inventive complexity.

Original Patent Information

Patent NumberUS 11,857,694
TitleParticles
Assignee(s)MicroVention, Inc.